TNXP - Tonix Pharmaceuticals Holding Corp.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 22.03M
Enterprise value -97.44M
Trailing P/E 0.29
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.11
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.83

Trading information

Stock price history

Beta (5Y monthly) 2.18
52-week change 3-89.05%
S&P500 52-week change 31.77%
52-week high 329.9375
52-week low 31.6500
50-day moving average 32.9472
200-day moving average 34.1493

Share statistics

Avg vol (3-month) 3210.02k
Avg vol (10-day) 3361.09k
Shares outstanding 510.34M
Implied shares outstanding 6N/A
Float 810.13M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short (14 May 2023) 4638.81k
Short ratio (14 May 2023) 42.68
Short % of float (14 May 2023) 46.18%
Short % of shares outstanding (14 May 2023) 46.18%
Shares short (prior month 13 Apr 2023) 4231.65k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 331 Oct 2019
Ex-dividend date 4N/A
Last split factor 216:100
Last split date 309 May 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-37.10%
Return on equity (ttm)-62.57%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -118.05M
Net income avi to common (ttm)-123.47M
Diluted EPS (ttm)-13.3800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)71.97M
Total cash per share (mrq)7.1
Total debt (mrq)N/A
Total debt/equity (mrq)0.62
Current ratio (mrq)6.40
Book value per share (mrq)16.32

Cash flow statement

Operating cash flow (ttm)-99.92M
Levered free cash flow (ttm)-94.94M